ESW Launches GovCon Accelerator™: A First-of-Its-Kind Framework for Secure, Compliance-Driven Microsoft 365 Deployments in GCC High 
Indonesia’s Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership 
Tradelink and Fadada Sign Strategic Agreement to Promote Secure Cross-Border Digital Signing Solutions in Hong Kong TSX-V Grant Solarvest CLR Extension to August 31, 2023
Vancouver, British Columbia–(Newsfile Corp. – July 24, 2023) – Further to press release dated May…
SunLink Health Systems, Inc. Announces the Election of Mark J. Stockslager as Director to Board of Directors
ATLANTA–(BUSINESS WIRE)–On July 20, 2023, the board of directors (the “Board”) of SunLink Health Systems,…
Duchesnay Pharmaceutical Group selected as one of first participants in federal government’s Global Hypergrowth Project
Winners of rigorous competition become ambassadors for Canadian economic growth and will benefit from access…
EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023
ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023 Strong growth in half-year core…
ORYZON Reports Financial Results and Corporate Updates for Half-Year Ending June 30, 2023
Positive aggregate safety data from vafidemstat’s PORTICO Phase IIb trial in Borderline Personality Disorder (BPD),…
ABVC BioPharma Announces Reverse Stock Split
FREMONT, CA, July 24, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”),…
Intermap Partners with CAPE Analytics for Property Intelligence Analytics
NEXTMap® data bolsters CAPE’s multisource approach to AI-backed property analytics DENVER, July 24, 2023 (GLOBE…
Kiromic BioPharma Welcomes Two New Directors to its Board
Clinical and Regulatory Affairs Expert Pamela Misajon Brings Drug-Development Expertise Finance and Technology Executive Michael…
First BanCorp Announces Capital Actions
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–First BanCorp. (the “Corporation”) (NYSE: FBP), the bank holding company for…
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) — GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight”…
22nd Century Announces Executive Leadership Changes
Expands Board with New Highly Accomplished Independent Director Strengthens Balance Sheet and Implements $15 Million…
Enhancing Investor Confidence: Sibble & Associates Debuts Advanced SaaS Product for Comprehensive Technical Due Diligence
CAMBRIDGE, Mass., July 24, 2023 (GLOBE NEWSWIRE) — Sibble & Associates, a leading provider of…
Sequans Announces Conference Call to Review Second Quarter 2023 Results
Tuesday, August 8, 2023 at 8:00 a.m. ET Paris, France–(Newsfile Corp. – July 24, 2023)…
Ameresco Awarded Top Project of the Year by Environment + Energy Leader for partnership with Holy Cross Energy and Colorado Mountain College
Ameresco’s Solar-plus-storage Project with Holy Cross Energy/Colorado Mountain College Receives Top Project of the Year…
 DocGo to Announce Second Quarter 2023 Results on Monday, August 7th
Management to host investor conference call and webcast at 5:00pm EDT on that day NEW…
Ellington Financial Reports Preliminary Results for Second Quarter 2023
OLD GREENWICH, Conn.–(BUSINESS WIRE)–Ellington Financial Inc. (NYSE: EFC) (the “Company”) today disclosed the following estimated…
Public Storage Accelerates Growth with Simply Self Storage Acquisition
GLENDALE, California and New York–(BUSINESS WIRE)–Public Storage (NYSE:PSA) (the “Company”) and Blackstone Real Estate Income…
Apellis Pharmaceuticals to Host Conference Call on July 31, 2023, to Discuss Second Quarter 2023 Financial Results
WALTHAM, Mass., July 24, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Apellis Pharmaceuticals to Host Conference Call on July 31, 2023, to Discuss Second Quarter 2023 Financial Results
WALTHAM, Mass., July 24, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch
Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship…